- Home
- CTRM vs CARA Comparison
CTRM vs CARA Comparison
Compare CTRM & CARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRM
- CARA
- Stock Information
- Founded
- CTRM 2016
- CARA 2004
- Country
- CTRM Cyprus
- CARA United States
- Employees
- CTRM N/A
- CARA N/A
- Industry
- CTRM Marine Transportation
- CARA Biotechnology: Pharmaceutical Preparations
- Sector
- CTRM Consumer Discretionary
- CARA Health Care
- Exchange
- CTRM Nasdaq
- CARA Nasdaq
- Market Cap
- CTRM 26.7M
- CARA 23.1M
- IPO Year
- CTRM N/A
- CARA 2014
- Fundamental
- Price
- CTRM $2.63
- CARA $4.93
- Analyst Decision
- CTRM
- CARA Hold
- Analyst Count
- CTRM 0
- CARA 3
- Target Price
- CTRM N/A
- CARA $12.00
- AVG Volume (30 Days)
- CTRM 42.8K
- CARA 54.1K
- Earning Date
- CTRM 02-14-2025
- CARA 03-03-2025
- Dividend Yield
- CTRM N/A
- CARA N/A
- EPS Growth
- CTRM N/A
- CARA N/A
- EPS
- CTRM 2.39
- CARA N/A
- Revenue
- CTRM $76,443,340.00
- CARA $8,686,000.00
- Revenue This Year
- CTRM N/A
- CARA N/A
- Revenue Next Year
- CTRM N/A
- CARA N/A
- P/E Ratio
- CTRM $1.11
- CARA N/A
- Revenue Growth
- CTRM N/A
- CARA N/A
- 52 Week Low
- CTRM $2.47
- CARA $2.71
- 52 Week High
- CTRM $5.49
- CARA $13.80
- Technical
- Relative Strength Index (RSI)
- CTRM 35.60
- CARA 50.03
- Support Level
- CTRM $2.65
- CARA $4.81
- Resistance Level
- CTRM $2.73
- CARA $5.28
- Average True Range (ATR)
- CTRM 0.08
- CARA 0.45
- MACD
- CTRM 0.01
- CARA -0.06
- Stochastic Oscillator
- CTRM 41.98
- CARA 28.24
About CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under two reportable segments namely Dry bulk; Aframax/LR2 tanker; Handysize tanker and Container ship. It generates maximum revenue from the Dry bulk segment.
About CARA Cara Therapeutics Inc.
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.